SCHEMBL5100660

SCHEMBL5100660

CCCCCCC#CC=CC#Cc1cccs1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.40
ADORA3 P0DMS8 3/20 0.39
ADORA2A P29274 3/20 0.39
HMGCR P04035 2/20 0.36
ADORA1 P30542 1/20 0.35
ADORA2B P29275 1/20 0.35
FFAR1 O14842 2/20 0.35
FFAR4 Q5NUL3 1/20 0.35
MMP2 P08253 1/20 0.34
MMP12 P39900 1/20 0.34
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
GRM5 P41594 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5100651 1.00 KCNH2 (0.40) KCNH2ADORA3ADORA2AHMGCRADORA1
SCHEMBL1897640 0.85 KCNH2 (0.50) KCNH2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL7684841 0.85 KCNH2 (0.50) KCNH2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL1898264 0.83 KCNH2 (0.49) KCNH2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL7063023 0.83 KCNH2 (0.47) KCNH2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL28663062 0.78 ADORA3 (0.45) KCNH2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL5092667 0.78 FFAR1 (0.48) KCNH2HMGCRFFAR1FFAR4MMP2
SCHEMBL5092657 0.78 FFAR1 (0.48) KCNH2HMGCRFFAR1FFAR4MMP2
SCHEMBL5095343 0.74 FFAR1 (0.44) KCNH2HMGCRFFAR1FFAR4MMP2
SCHEMBL5095348 0.74 FFAR1 (0.44) KCNH2HMGCRFFAR1FFAR4MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B KCNH2 1925/4885ADORA3 1815/4885ADORA2A 3153/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A KCNH2 619/4885ADORA3 2514/4885ADORA2A 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.